Investment community reaction to Eton Pharmaceuticals' solid...

Investment community reaction to Eton Pharmaceuticals' solid earnings was subdued. Suggestions indicate the company's statutory profit could be underestimating its earnings potential, especially following its profitable rebound after last year's loss.